• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    How Globe Life’s Higher 2026 Earnings Guidance Will Impact Globe Life (GL) Investors

    Simply Wall St·02/19/2026 17:34:22
    Listen to the news
    • In early February 2026, Globe Life Inc. raised its full-year 2026 earnings guidance, projecting net operating income between $14.95 and $15.65 per diluted share, signaling management’s updated expectations for the business.
    • This guidance increase offers investors a clearer benchmark for assessing how Globe Life’s capital deployment, underwriting discipline, and distribution initiatives are translating into expected profitability.
    • We’ll now examine how Globe Life’s higher 2026 earnings guidance reshapes the existing investment narrative around its long-term earnings power.

    Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

    Globe Life Investment Narrative Recap

    To own Globe Life, you need to believe it can keep converting a focused life and supplemental health franchise into steady earnings, despite reliance on traditional agents and sensitivity to economic and regulatory shocks. The higher 2026 earnings guidance tightens the near term focus on execution: it supports the case that underwriting and investment income are holding up, but it does not remove key risks around distribution shifts, investigations, or interest rate and credit conditions.

    The recent Q4 2025 results, with full year net income of US$1,161.24 million and diluted EPS of US$14.07, form an important backdrop for the updated 2026 outlook. Together, the reported earnings and higher guidance give investors a more concrete yardstick to judge whether Globe Life’s capital deployment, including ongoing buybacks, and its underwriting performance are reinforcing, or straining, the core earnings story that underpins the stock.

    Yet against this improved guidance, the ongoing DOJ and SEC investigations remain a risk investors should be aware of, especially if...

    Read the full narrative on Globe Life (it's free!)

    Globe Life’s narrative projects $6.8 billion revenue and $1.3 billion earnings by 2028. This requires 5.1% yearly revenue growth and about a $0.2 billion earnings increase from $1.1 billion today.

    Uncover how Globe Life's forecasts yield a $171.40 fair value, a 19% upside to its current price.

    Exploring Other Perspectives

    GL 1-Year Stock Price Chart
    GL 1-Year Stock Price Chart

    Before this guidance raise, the most optimistic analysts were already assuming earnings of about US$1.3 billion by 2028, but if rising health claims persist, you may see that bullish view tested in very different ways.

    Explore 2 other fair value estimates on Globe Life - why the stock might be worth just $171.40!

    Decide For Yourself

    Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

    Seeking Other Investments?

    These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.